Curcuma longa (turmeric) or its active ingredients for osteoarthritis

Ivan Shirinsky; Valery Shirinsky; Katerina Filatova; Zeyu Yu; Yuan Chi; Jacqueline Y. Thompson; Chris Bleakley

doi:10.1002/14651858.CD014683

Curcuma longa (turmeric) or its active ingredients for osteoarthritis

Ivan Shirinsky^*, Valery Shirinsky, Katerina Filatova, Zeyu Yu, Yuan Chi, Jacqueline Y. Thompson, Chris Bleakley

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

87 Downloads (Pure)

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the benefits and harms of Curcuma longa extracts or сurcuminoids for osteoarthritis.

Original language	English
Article number	CD014683
Number of pages	15
Journal	Cochrane Database of Systematic Reviews
Volume	2021
Issue number	7
DOIs	https://doi.org/10.1002/14651858.CD014683
Publication status	Published - 12 Jul 2021

Bibliographical note

Funding Information:
The methods section is based on the standard Cochrane Musculoskeletal Group Protocol Template. Peer reviewer Dr Benny Antony Senior Research Fellow, Menzies Institute for Medical Research, University of Tasmania and Ms Maureen Smith, Cochrane Consumer, are acknowledged.

Publisher Copyright:
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

ASJC Scopus subject areas

Pharmacology (medical)

Access to Document

10.1002/14651858.CD014683

ShirinskyI2021Curcuma
This Protocol of a Cochrane Review was published in the Cochrane Database of Systematic Reviews 2021, Issue 7. Cochrane Protocols and Reviews are regularly updated as new evidence emerges and in response to feedback, and the Cochrane Database of Systematic Reviews should be consulted for the most recent version of the Protocol. Authors. Curcuma longa (turmeric) or its active ingredients for osteoarthritis (Protocol). Cochrane Database of Systematic Reviews 2021, Issue 7. Art. No.: CDD014683. DOI: 10.1002/14651858.CD014683
Accepted author manuscript, 211 KBLicence: None: All rights reserved

Cite this

@article{70bbd454cc954ceea7fcf4e4e8ed0a3e,

title = "Curcuma longa (turmeric) or its active ingredients for osteoarthritis",

abstract = "Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the benefits and harms of Curcuma longa extracts or сurcuminoids for osteoarthritis.",

author = "Ivan Shirinsky and Valery Shirinsky and Katerina Filatova and Zeyu Yu and Yuan Chi and Thompson, {Jacqueline Y.} and Chris Bleakley",

note = "Funding Information: The methods section is based on the standard Cochrane Musculoskeletal Group Protocol Template. Peer reviewer Dr Benny Antony Senior Research Fellow, Menzies Institute for Medical Research, University of Tasmania and Ms Maureen Smith, Cochrane Consumer, are acknowledged. Publisher Copyright: Copyright {\textcopyright} 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.",

year = "2021",

month = jul,

day = "12",

doi = "10.1002/14651858.CD014683",

language = "English",

volume = "2021",

journal = "Cochrane Database of Systematic Reviews",

issn = "1465-1858",

publisher = "Cochrane Collaboration",

number = "7",

}

TY - JOUR

T1 - Curcuma longa (turmeric) or its active ingredients for osteoarthritis

AU - Shirinsky, Ivan

AU - Shirinsky, Valery

AU - Filatova, Katerina

AU - Yu, Zeyu

AU - Chi, Yuan

AU - Thompson, Jacqueline Y.

AU - Bleakley, Chris

N1 - Funding Information: The methods section is based on the standard Cochrane Musculoskeletal Group Protocol Template. Peer reviewer Dr Benny Antony Senior Research Fellow, Menzies Institute for Medical Research, University of Tasmania and Ms Maureen Smith, Cochrane Consumer, are acknowledged. Publisher Copyright: Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

PY - 2021/7/12

Y1 - 2021/7/12

N2 - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the benefits and harms of Curcuma longa extracts or сurcuminoids for osteoarthritis.

AB - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the benefits and harms of Curcuma longa extracts or сurcuminoids for osteoarthritis.

UR - http://www.scopus.com/inward/record.url?scp=85110472027&partnerID=8YFLogxK

U2 - 10.1002/14651858.CD014683

DO - 10.1002/14651858.CD014683

M3 - Article

AN - SCOPUS:85110472027

SN - 1465-1858

VL - 2021

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 7

M1 - CD014683

ER -

Curcuma longa (turmeric) or its active ingredients for osteoarthritis

Abstract

Bibliographical note

ASJC Scopus subject areas

Access to Document

Fingerprint

Cite this